Results 101 to 110 of about 117,950 (235)

Hemodynamic comparison of polyurethane trileaflet and tissue heart valve prostheses

open access: yes, 1988
In this paper, a hemodynamic comparison of two polyurethane trileaflet heart valve prostheses with currently available biological tissue valve prostheses are made. The valves, sutured to a valve mounting ring are incorporated in a mock circulatory system
Wurzel, D.   +6 more
core  

The Caged-Ball Prosthesis 60 Years Later: A Historical Review of a Cardiac Surgery Milestone

open access: yes, 2022
Sixty years ago, 2 cardiac operations dramatically influenced the survival of patients with valvular heart disease. The replacement of an aortic valve by Dwight Harken and of a mitral valve by Albert Starr with mechanical caged-ball valves, both in 1960,
Thiene, Gaetano   +5 more
core   +1 more source

Validation of Aortic Blood Flow Simulations During Extracorporeal Circulation Using Phase Contrast Magnetic Resonance Imaging

open access: yesArtificial Organs, EarlyView.
This is the first study assessing in vivo blood flow profiles during extracorporeal circulation (ECC) scenarios. Magnetic resonance imaging data served for the calibration of computational fluid dynamics algorithms, enabling accurate replication of the hemodynamic conditions.
Anna Kathrin Assmann   +9 more
wiley   +1 more source

Bileaflet mechanical heart valves thrombosis: in vitro detection by artificial neural networks.

open access: yes, 2010
Endothelial pannus and thrombus formation which usually deposit on bileaflet mechanical heart valves progressively lead to incomplete opening of the valve. At the final state, they block the hinge-leaflet mechanism and cause embolic events.
PENGO, VITTORIO   +7 more
core  

Comparison of Intraoperative Doppler Flow Measurements and Algorithmic Flow Estimations in Patients Undergoing Durable Left Ventricular Assist Device Implantation

open access: yesArtificial Organs, EarlyView.
Direct intraoperative HeartMate 3 LVAD flow measurements using an ultrasonic probe revealed consistently higher values by approximately 0.5 L/min compared to device‐estimated flows. This discrepancy remained stable across pump speed settings, highlighting the importance of distinguishing measured from estimated flow in HeartMate 3 patients.
Gaik Nersesian   +13 more
wiley   +1 more source

Estudo multicêntrico da bioprótese porcina Labcor Multicenter study with porcine bioprosthetic Labcor valve

open access: yesBrazilian Journal of Cardiovascular Surgery, 1988
No período de 1984-1988, foram estudados 514 pacientes, 288 do sexo feminino e 226 do sexo masculino, com idade de 36,8 ± 16,5 anos, submetidos a cirurgia cardíaca valvar com implante de bioprótese porcina Labcor.
Fernando A Lucchese   +15 more
doaj  

Case Series on Prosthetic Valve Thromboses Treated with Intravenous Thrombolysis at a Tertiary Teaching Hospital in Nairobi – Kenya

open access: yesJournal of Kenya Association of Physicians
Valvular heart disease is a significant global health issue, particularly in developing countries where Rheumatic Heart Disease (RHD) is the leading cause.
John Otieno Odhiambo   +2 more
doaj   +1 more source

Identification of Autologous Tissue Sources and Optimization of a Treatment Method for Intraoperative Manufacturing of Heart Valve Constructs

open access: yesArtificial Organs, EarlyView.
The use of autologous connective tissue, such as pericardium or peritoneum, combined with controlled tissue treatment, has the potential to result in a more durable heart valve prosthesis than current commercial prostheses. ABSTRACT Introduction Valvular heart disease remains a leading cause of morbidity and mortality. Current biological and mechanical
Marvin Steitz   +17 more
wiley   +1 more source

Design, manufacturing and testing of a green non-isocyanate polyurethane prosthetic heart valve.

open access: yesBiomaterials Science
The sole effective treatment for most patients with heart valve disease is valve replacement by implantation of mechanical or biological prostheses. However, mechanical valves represent high risk of thromboembolism, and biological prostheses are prone to
Sofia F Melo   +21 more
semanticscholar   +1 more source

The Immune Response in In Situ Tissue Engineering of Aortic Heart Valves

open access: yes, 2013
The gold standard for treatment of advanced heart valve disease is surgical heart valve re‐ placement. None of the currently available mechanical and bioprosthetic heart valve substi‐ tutes resembles normal heart valve function.
S. Loon   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy